ITM-52

N/A

Report date: 2025/09/10 10:58:24

Base Information

Drug NameITM-52

Drug Alias NameITM-52225Ac-FRαTM225Ac-ITM-52

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionIonising radiation emitters

TargetsFolate receptor alpha

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMerck KGaA, Darmstadt, Germany

China Registration ClassN/A

Develop Information

Active CompaniesITM Isotope Technologies Munich SE

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A